Rocket Lab USA, Inc. — Q1 2024 Form 10-Q
Reporting period: Three months ended March 31, 2024. Amounts below are in U.S. dollars; financial figures are in millions unless stated otherwise. Rocket Lab operates two reportable segments: Launch Services and Space Systems, providing launch, spacecraft, component, manufacturing and mission services.
Financial performance and liquidity
| Metric | Q1 2024 | Q1 2023 |
|---|---|---|
| Revenue | $92.8 | $54.9 |
| Gross profit / margin | $24.2 / 26.1% | $6.4 / 11.6% |
| Operating loss | $(43.1) / (46.4)% of revenue | $(46.0) / (83.8)% of revenue |
| Net loss | $(44.3) | $(45.6) |
| Net loss per share, diluted | $(0.09) | $(0.10) |
| Cash used in operating activities | $(2.6) | $(25.4) |
| Capital expenditures | $19.2 | $12.7 |
Revenue rose 69% year over year. Space Systems revenue was $60.0 million, up 70%, primarily on spacecraft manufacturing growth; Launch Services revenue was $32.7 million, up 67%, reflecting four launches versus three and higher revenue per launch. Management reported revenue per launch of $8.2 million versus $6.5 million; cost per launch was $6.1 million versus $7.5 million, excluding a $2.1 million nonrecurring employee retention credit in 2023.
Gross margin improved substantially as revenue grew faster than cost of revenue. Segment gross profit was $15.8 million for Space Systems and $8.4 million for Launch Services, compared with $7.1 million and a $0.8 million loss, respectively, in the prior-year quarter. R&D expense increased 61% to $38.5 million, mainly due to Neutron development, hiring and prototype spending; SG&A was broadly flat at $28.7 million.
At March 31, 2024, cash and cash equivalents were $365.9 million and marketable securities totaled $195.2 million, or $561.1 million combined. Total current assets were $725.6 million and current liabilities $232.5 million. Principal indebtedness was $421.8 million: $355.0 million of 4.250% convertible notes due 2029 and $66.8 million under the Trinity equipment financing agreement. $11.0 million of debt principal was scheduled to fall due within 12 months. Minimum lease payments totaled $107.2 million, including $10.9 million due within 12 months.
Management said existing cash, cash equivalents and customer payments should meet working-capital and capital-expenditure needs for at least the next 12 months, while noting it may pursue additional financing. Net cash from financing was $258.7 million, principally reflecting the $355.0 million note issuance, offset in part by $43.2 million of Trinity repayments, $43.2 million for capped calls and $11.2 million of debt issuance costs. The company ended the quarter with $203.3 million more cash, cash equivalents and restricted cash than at year-end.
Material changes and business indicators
- Backlog declined to $1,015.3 million from $1,046.1 million at December 31, 2023: $215.6 million Launch Services and $799.7 million Space Systems. About 42% was expected to be recognized within 12 months. Backlog may be affected by customer termination rights.
- Operating cash use narrowed from $25.4 million to $2.6 million, aided by working-capital movements, including increases in contract liabilities. It should not be read as equivalent to positive earnings or as a forecast of future cash use.
- Contract liabilities increased to $150.5 million from $139.3 million. The company recognized $57.2 million of revenue from opening contract liabilities and received or billed $68.4 million in customer advances during the quarter.
- Research and development spending increased to support product development; inventory decreased to $99.9 million from $107.9 million. Capital expenditures rose to $19.2 million from $12.7 million.
- The company completed four launches during Q1 and five through May 6, 2024. It reported 42 successful Electron missions and delivery of more than 180 spacecraft to orbit through March 31.
Outlook, risks and unusual items
- Neutron: Rocket Lab began its Archimedes engine test campaign and revised first-flight timing to no earlier than mid-2025. Development delays or cost increases could affect expected growth and spending.
- Spending and profitability: Management expects continued investment in products, facilities, personnel and production capacity. It expects cost of revenue to increase in absolute dollars as sales grow and anticipates margin improvement over time, but notes production inefficiencies, cost overruns and supply interruptions could impede it.
- Convertible financing: The company issued $355.0 million of 4.250% senior unsecured notes due 2029. It paid $43.2 million for capped calls intended to reduce potential dilution or conversion cash costs, subject to a cap. The notes’ initial conversion price was approximately $5.13 per share; the capped-call cap price was $8.04.
- Other debt item: The company repaid the Trinity Blanket Lien Draw in February and recorded a $1.3 million loss on extinguishment. The remaining Trinity financing had a disclosed effective interest rate of 14.8%.
- Contingency: A $7.1 million provision for expected losses, primarily related to a fixed-price solar-panel module contract, was included in other current liabilities. Management said ordinary-course litigation was not expected to have a material adverse effect.
- Customer concentration: MDA represented 25% of Q1 revenue; a U.S. government customer represented 12%. Lockheed Martin, MDA and Northrop Grumman represented 17%, 14% and 13% of accounts receivable, respectively.
- Risks: The filing highlights launch cadence and failure risk, Neutron development, customer funding and concentration, government contract and funding exposure, supply-chain constraints, competition, foreign exchange, inflation, cybersecurity, recruiting and the possibility that additional capital may not be available on acceptable terms. Rocket Lab reported no material change to previously disclosed risk factors and no material adverse legal claims.
- Management reported effective disclosure controls as of March 31, 2024, with no material changes in internal control over financial reporting during the quarter.
Important facts for investors to verify
- Whether Neutron engine testing and the revised first-flight schedule remain on track, and how development spending affects losses and cash use.
- Whether backlog converts to revenue on schedule, considering customer termination rights, contract estimates and the timing of milestone payments.
- Whether improved gross margins and lower operating cash use are sustained as launch cadence and Space Systems production scale.
- Liquidity after debt service, capital expenditures and lease commitments; the remaining Trinity financing carries a stated 14.8% effective interest rate.
- Potential dilution and cash settlement exposure under the convertible notes, including the capped calls’ price limits and conversion terms.
- Progress resolving the loss-making solar-panel contract and managing customer concentration and government funding exposure.